SUPERNUS PHARMACEUTICALS INC USD0.001 earnings per share and revenue

0LB2 earnings per share for the last quarter are 0.00 USD whereas the estimation was 0.26 USD which accounts for -100.00% surprise. Företagets omsättning för samma period uppgår till 143.64 M USD trots den uppskattade siffran 145.83 M USD. Estimated earnings per share for the next quarter are 0.39 USD, and revenue is expected to reach 148.85 M USD. Also watch annual changes over time to get a bigger picture of 0LB2 earnings per share and revenue dynamics.